Pharmacotherapy

Article	Citations
Remdesivir: Review of Pharmacology, Pre‐clinical Data, and Emerging Clinical Experience for COVID‐19	188
Review of Emerging Pharmacotherapy for the Treatment of Coronavirus Disease 2019	153
Baricitinib: A Review of Pharmacology, Safety, and Emerging Clinical Experience in COVID‐19	141
COVID‐19 Clinical Diagnostics and Testing Technology	104
Therapeutic Potential for Tetracyclines in the Treatment of COVID‐19	88
Considerations for Statin Therapy in Patients with COVID‐19	78
Managing COVID‐19 in Renal Transplant Recipients: A Review of Recent Literature and Case Supporting Corticosteroid‐sparing Immunosuppression	67
Immunosuppression trends in solid organ transplantation: The future of individualization, monitoring, and management	63
A guide to therapeutic drug monitoring of β‐lactam antibiotics	62
Coagulopathy, Venous Thromboembolism, and Anticoagulation in Patients with COVID‐19	54
Vancomycin‐Induced Kidney Injury: Animal Models of Toxicodynamics, Mechanisms of Injury, Human Translation, and Potential Strategies for Prevention	48
Delayed Initiation of Remdesivir in a COVID‐19‐Positive Patient	48
Acetylcysteine for the Treatment of Suspected Remdesivir‐Associated Acute Liver Failure in COVID‐19: A Case Series	44
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and the I	39
Tacrolimus intrapatient variability in solid organ transplantation: A multiorgan perspective	35
Adverse Effects of Antidepressant Medications and their Management in Children and Adolescents	31
Cefiderocol: A Novel Siderophore Cephalosporin against Multidrug‐Resistant Gram‐Negative Pathogens	29
Drug‐Induced Ototoxicity: A Comprehensive Review and Reference Guide	28
Meta‐analysis of clinical outcomes of PCSK9 modulators in patients with established ASCVD	27
An Overview of the Treatment of Less Common Non–Lactose‐Fermenting Gram‐Negative Bacteria	26
Beneficial and harmful outcomes of tocilizumab in severe COVID‐19: A systematic review and meta‐analysis	25
Approach to the Treatment of Patients with Serious Multidrug‐Resistant Pseudomonas aeruginosa Infections	25
Buprenorphine initiation strategies for opioid use disorder and pain management: A systematic review	24
Optimizing anticoagulation for patients receiving Impella support	24
Role of maternal COVID‐19 vaccination in providing immunological protection to the newborn	23

CYP2D6 Genetic Polymorphisms and Risperidone Pharmacokinetics: A Systematic Review and Meta‐analysis	23
Treatment of patients with serious infections due to carbapenem‐resistant Acinetobacter baumannii: How viable are the current options?	23
Comparison of high‐dose dual therapy with bismuth‐containing quadruple therapy in Helicobacter pylori‐infected treatment‐naive patients: An open‐label, multicenter, randomized controlled trial	23
Food effects on the formulation, dosing, and administration of cannabidiol (CBD) in humans: A systematic review of clinical studies	20
CBD and THC: Do They Complement Each Other Like Yin and Yang?	20
Analgesia and Sedation Strategies in Mechanically Ventilated Adults with COVID‐19	19
Effect of Preinjury Oral Anticoagulants on Outcomes Following Traumatic Brain Injury from Falls in Older Adults	19
Akathisia and Newer Second‐Generation Antipsychotic Drugs: A Review of Current Evidence	19
Systematic Review of Crizanlizumab: A New Parenteral Option to Reduce Vaso‐occlusive Pain Crises in Patients with Sickle Cell Disease	19
Combination of Vancomycin or Daptomycin and Beta‐lactam Antibiotics: A Meta‐analysis	18
Emerging therapies for the treatment of nonalcoholic steatohepatitis: A systematic review	18
Antibiotics in the Biliary Tract: A Review of the Pharmacokinetics and Clinical Outcomes of Antibiotics Penetrating the Bile and Gallbladder Wall	18
Systematic Review of Voxelotor: A First‐in‐Class Sickle Hemoglobin Polymerization Inhibitor for Management of Sickle Cell Disease	17
Gut microbiome health and dysbiosis: A clinical primer	17
Risk of Venous Thromboembolism Associated With Tofacitinib and Baricitinib: A Systematic Review and Indirect Meta‐Analysis	16
Scoping review of augmented renal clearance in critically ill pediatric patients	16
Use of oral tetracyclines in the treatment of adult outpatients with skin and skin structure infections: Focus on doxycycline, minocycline, and omadacycline	16
DPYD and UGT1A1 Pharmacogenetic Testing in Patients with Gastrointestinal Malignancies: An Overview of the Evidence and Considerations for Clinical Implementation	15
Systematic review and meta‐analysis of the correlation between bispectral index (BIS) and clinical sedation scales: Toward defining the role of BIS in critically ill patients	15
Association of proton pump inhibitor use with endothelial function and metabolites of the nitric oxide pathway: A cross‐sectional study	15
Cisplatin‐induced nephrotoxicity in an outpatient setting	15
Use of direct‐acting oral anticoagulants in solid organ transplantation: A systematic review	15
Therapeutic review of cabotegravir/rilpivirine long‐acting antiretroviral injectable and implementation considerations at an HIV specialty clinic	15
Long‐term Follow‐up of Hematopoietic Stem Cell Transplant Survivors: A Focus on Screening, Monitoring, and Therapeutics	14
Corticosteroid use in ARDS and its application to evolving therapeutics for coronavirus disease 2019 (COVID‐19): A systematic review	14
Potential Implications of Gut Microbiota in Drug Pharmacokinetics and Bioavailability	14
Physiologically based pharmacokinetic modeling of tramadol to inform dose adjustment and drug‐drug interactions according to CYP2D6 phenotypes	14
A systematic review of the drug–drug interaction between statins and colchicine: Patient characteristics, etiologies, and clinical management strategies	14
Race and sex associations with tacrolimus pharmacokinetics in stable kidney transplant recipients	13
Combining Antidepressants with β‐Blockers: Evidence of a Clinically Significant CYP2D6 Drug Interaction	13
Vancomycin area under the curve versus trough only guided dosing and the risk of acute kidney injury: Systematic review and meta‐analysis	13
Alopecia signals associated with calcitonin gene‐related peptide inhibitors in the treatment or prophylaxis of migraine: A pharmacovigilance study	12
Bamlanivimab use in mild‐to‐moderate COVID‐19 disease: A matched cohort design	12
Advances in CAR T Therapy for Hematologic Malignancies	12
Comparison of Bayesian‐derived and first‐order analytic equations for calculation of vancomycin area under the curve	12
Prophylactic norepinephrine infusion for postspinal anesthesia hypotension in patients undergoing cesarean section: A randomized, controlled, dose‐finding trial	12
The association between urate‐lowering therapies and treatment‐related adverse events, liver damage, and major adverse cardiovascular events (MACE): A network meta‐analysis of randomized trials	12
Use of psychiatric medication by college students: A decade of data	12
Evolving Therapeutic Options for Chronic Graft‐versus‐Host Disease	12
Tebipenem pivoxil hydrobromide—No PICC, no problem!	11
Glucagon: Its evolving role in the management of hypoglycemia	11
Multi‐center retrospective study evaluating the efficacy and safety of apixaban versus warfarin for treatment of venous thromboembolism in patients with severe obesity	11
Cardiovascular and kidney outcomes of spironolactone or eplerenone in combination with ACEI/ARBs in patients with diabetic kidney disease	11
Myocardial infarction associated with erenumab: A case report	11
Poor tolerability of cystic fibrosis transmembrane conductance regulator modulator therapy in lung transplant recipients	11
Prescription Medication Use in Older Adults Without Major Cardiovascular Disease Enrolled in the Aspirin in Reducing Events in the Elderly (ASPREE) Clinical Trial	11
The impact of statin use prior to intensive care unit admission on critically ill patients with sepsis	11
National Trends in Oral Antibiotic Prescribing in United States Physician Offices from 2009 to 2016	10
Achievement of goal anti‐Xa activity with weight‐based enoxaparin dosing for venous thromboembolism prophylaxis in trauma patients	10
Pneumococcal vaccination—A literature review and practice guideline update	10

Statin‐associated muscle symptoms—A review: Individualizing the approach to optimize care	10
Utility of triazole antifungal therapeutic drug monitoring: Insights from the Society of Infectious Diseases Pharmacists	10
Hydroxychloroquine in Hospitalized Patients with COVID‐19: Real‐World Experience Assessing Mortality	10
Current therapies and challenges for the treatment of Staphylococcus aureus biofilm‐related infections	10
Early combination therapy with immunoglobulin and steroids is associated with shorter ICU length of stay in Multisystem Inflammatory Syndrome in Children (MIS‐C) associated with	10
Reduced alternative insulin dosing in hyperkalemia: A meta‐analysis of effects on hypoglycemia and potassium reduction	10
Omega‐3 fatty acids for the prevention of atherosclerotic cardiovascular disease	10
Anticholinergic medication burden and cognitive function in participants of the ASPREE study	10
Optimization of Vancomycin Dosing Regimen in Cancer Patients using Pharmacokinetic/Pharmacodynamic Modeling	10
Cefazolin in the treatment of central nervous system infections: A narrative review and recommendation	9
Methadone‐associated QT interval prolongation in patients undergoing maintenance therapy in an urban opioid treatment program	9
Response to intravenous racemic ketamine after switch from intranasal (S)‐ketamine on symptoms of treatment‐resistant depression and post‐traumatic stress disorder in Veterans: A retrospective case se	9
Antimicrobial susceptibility testing: An updated primer for clinicians in the era of antimicrobial resistance: Insights from the Society of Infectious Diseases Pharmacists	9
Safety and effectiveness of NMDA receptor antagonists for depression: A multidisciplinary review	9
Systematic review of drug–drug interactions between rifamycins and anticoagulant and antiplatelet agents and considerations for management	9
Consensus recommendations for use of maintenance immunosuppression in solid organ transplantation: Endorsed by the American College of Clinical Pharmacy, American Society of Transplantation, and Inter	9
Using l‐Carnitine as a Pharmacologic Probe of the Interpatient and Metabolic Variability of Sepsis	9
Use of oral anticoagulants among individuals with cancer and atrial fibrillation in the United States, 2010–2016	9
The role of inflammation in the pathogenesis and treatment of arrhythmias	8
A pragmatic assessment of proton pump inhibitors vs. histamine type 2 receptor antagonists on clinically important gastrointestinal bleeding and mortality when used for stress ulcer prophylaxis in the	8
Using Child‐Pugh Class to Optimize Voriconazole Dosage Regimens and Improve Safety in Patients with Liver Cirrhosis: Insights from a Population Pharmacokinetic Model‐based Analysis	8
Safety of elexacaftor/tezacaftor/ivacaftor dose reduction: Mechanistic exploration through physiologically based pharmacokinetic modeling and a clinical case series	8
Apixaban and rivaroxaban use for atrial fibrillation in patients with obesity and BMI ≥50 kg/m2	8
Immunosuppression considerations in simultaneous organ transplant	8
Optimizing ceftaroline dosing in critically ill patients undergoing continuous renal replacement therapy	8
TheMPRINTHub Data, Model, Knowledge and Research Coordination Center: Bridging the gap in maternal–pediatric therapeutics research through data integration and pharmacometrics	8
NR3C2 genotype is associated with response to spironolactone in diastolic heart failure patients from the Aldo‐DHF trial	8
A Systematic Review and Meta‐Analysis of Metolazone Compared to Chlorothiazide for Treatment of Acute Decompensated Heart Failure	8
Safety and efficacy of a platelet glycoprotein Ib inhibitor for patients with non‐ST segment elevation myocardial infarction: A phase Ib/IIa study	8
Sulbactam‐durlobactam: A novel β‐lactam‐β‐lactamase inhibitor combination targeting carbapenem‐resistant Acinetobacter baumannii infections	8
Systematic literature review of insulin dose adjustments when initiating hemodialysis or peritoneal dialysis	8
Differences in Predicted Warfarin Dosing Requirements Between Hmong and East Asians Using Genotype‐Based Dosing Algorithms	7
Pharmacogenetics of P2Y12 receptor inhibitors	7
Treprostinil Attains Clinically Therapeutic Concentrations in Neonates with Pulmonary Hypertension on Extracorporeal Membrane Oxygenation Support	7
Factors influencing antibiotic duration in culture‐negative neonatal early‐onset sepsis	7
Molecular Adsorbent Recirculating System Therapy with Continuous Renal Replacement Therapy Enhanced Clearance of Piperacillin in a Pediatric Patient and Led to Failure to Attain Pharmacodynamic Target	7
Reversal of apixaban and rivaroxaban with andexanet alfa prior to invasive or surgical procedures	7
A retrospective analysis of bleeding risk with rivaroxaban, enoxaparin, and aspirin following total joint arthroplasty or revision	7
Successful prolonged treatment of a carbapenem‐resistant Acinetobacter baumannii hip infection with cefiderocol: A case report	7
Comparing newborn outcomes after prenatal exposure to individual antidepressants: A retrospective cohort study	7
Adequacy of cefepime concentrations in the early phase of critical illness: A case for precision pharmacotherapy	7
Patient risk factors for opioid‐related adverse drug events in hospitalized patients: A systematic review	7
Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage	7
Population pharmacokinetic model‐guided optimization of intravenous voriconazole dosing regimens in critically ill patients with liver dysfunction	7
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	7
Lack of drug interaction between levetiracetam and high‐dose methotrexate in patients with lymphoma	7
Machine learning to predict vasopressin responsiveness in patients with septic shock	6
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired‐hepatic function	6
Evaluation of dosing strategies and trough concentrations of vancomycin in patients undergoing continuous venovenous hemofiltration	6
Impact of Incremental Delays in Appropriate Therapy on the Outcomes of Hospitalized Adult Patients with Gram‐negative Bloodstream Infections: “Every day matters”	6
Advances in personalized medicine and noninvasive diagnostics in solid organ transplantation	6
Pharmacotherapy for durable left ventricular assist devices	6
Administration of rabies immunoglobulin: Improving evidence‐based guidance for wound infiltration	6
Safety and efficacy of cefiderocol for off‐label treatment indications: A systematic review	6
Melatonin Use in Hospitalized Children for Non‐Anesthetic Indications: A Systematic Review	6
First‐Dose Vancomycin Pharmacokinetics Versus Empiric Dosing on Area‐Under‐the‐Curve Target Attainment in Critically Ill Patients	6
Association of CYP2B6 genetic polymorphisms with bupropion and hydroxybupropion exposure: A systematic review and meta‐analysis	6
A systematic review of clozapine‐associated inflammation and related monitoring	6
Precision‐based approaches to delirium in critical illness: A narrative review	6
COVID‐19: The Uninvited Guest in the Intensive Care Unit — Implications for Pharmacotherapy	6
Restrictive resuscitation in patients with sepsis and mortality: A systematic review and meta‐analysis with trial sequential analysis	6
The safety of rapid infusion levetiracetam: A systematic review	6
Advances in the treatment of transthyretin cardiac amyloidosis: Current and emerging therapies	6
Tacrolimus time in therapeutic range and long‐term outcomes in heart transplant recipients	6
Pharmacokinetics of Vancomycin in Critically Ill Patients Undergoing Sustained Low‐Efficiency Dialysis	6
Modeling Kinetic Glomerular Filtration Rate in Adults with Stable and Unstable Kidney Function: Vancomycin as the Motivating Example	6
Use of therapeutic drug monitoring to characterize cefepime‐related neurotoxicity	6
TT genotype of the MMP‐9‐1562C/T polymorphism may be a risk factor for thrombolytic therapy‐induced hemorrhagic complications after acute ischemic stroke	6
Enoxaparin versus unfractionated heparin for venous thromboembolism prophylaxis in renally impaired ICU patients	6
Precision fluid and vasoactive drug therapy for critically ill patients	5
Comprehensive guidance for antibiotic dosing in obese adults: 2022 update	5
Pharmacokinetics and safety of lefamulin after single intravenous dose administration in subjects with impaired renal function and those requiring hemodialysis	5
Comparative effectiveness of early‐targeted use of fidaxomicin versus oral vancomycin among hospitalized veterans’ affairs patients with infections due to Clostridioides difficile	5
NONMEM population pharmacokinetics and Monte Carlo dosing simulations of imipenem in critically ill patients with life‐threatening severe infections during support with or without extracorporeal membr	5
Comparative effectiveness and safety of high‐dose rivaroxaban and apixaban for atrial fibrillation: A propensity score‐matched cohort study	5
Evaluation of Guideline Recommendations for Dual Antipseudomonal Therapy in Hospitalized Adults with Pneumonia Using Combination Antibiograms	5
Evaluation of anti‐factor Xa concentrations using a body mass index‐based enoxaparin dosing protocol for venous thromboembolism prophylaxis in trauma patients	5
Predictive Validity of a QTc Interval Prolongation Risk Score in the Intensive Care Unit	5
Use of Remdesivir in Myasthenia gravis and COVID‐19	5
Management of noncytotoxic extravasation injuries: A focused update on medications, treatment strategies, and peripheral administration of vasopressors and hypertonic saline	5

Early clinical trial data and real‐world assessment of COVID‐19 vaccines: Insights from the Society of Infectious Diseases Pharmacists	5
U.S. trends in prescription nonsteroidal anti‐inflammatory drug use among patients with cardiovascular disease, 1988–2016	5
Role of the gut microbiome in cardiovascular drug response: The potential for clinical application	5
Impact of Hospitalization and Medication Switching on Post‐discharge Adherence to Oral Anticoagulants in Patients With Atrial Fibrillation	5
Complementary Use of U.S. FDA’s Adverse Event Reporting System and Sentinel System to Characterize Direct Oral Anticoagulants‐Associated Cutaneous Small Vessel Vasculitis	5
Potentially Inappropriate Medication Combination with Opioids among Older Dental Patients: A Retrospective Review of Insurance Claims Data	5
A pharmacogenetic precision medicine approach to analgesia and sedation optimization in critically ill adults	5
Renin‐angiotensin‐aldosterone system inhibitors and major cardiovascular events and acute kidney injury in patients with coronary artery disease	5
Risks and mitigation strategies to prevent etoposide infusion‐related reactions in children	5
Association of GGH Promoter Methylation Levels with Methotrexate Concentrations in Chinese Children with Acute Lymphoblastic Leukemia	5
Effects of GLP‐1 receptor agonists on cardiovascular outcomes in patients with type 2 diabetes and chronic kidney disease: A systematic review and meta‐analysis	5
Chemotherapy‐associated cardiomyopathy: Mechanisms of toxicity and cardioprotective strategies	5
The effect of antipsychotic treatment on hormonal, inflammatory, and metabolic biomarkers in healthy volunteers: A systematic review and meta‐analysis	4
Pharmacotherapy considerations in transgender individuals living with human immunodeficiency virus	4
A systematic review of direct acting antiviral therapies in hepatitis C virus‐negative liver transplant recipients of hepatitis C‐viremic donors	4
Effects of Co‐administration of Sulfonylureas and Antimicrobial Drugs on Hypoglycemia in Patients with Type 2 Diabetes Using a Case‐Crossover Design	4
Efficacy of risdiplam in spinal muscular atrophy: A systematic review and meta‐analysis	4
Extracorporeal treatments for isoniazid poisoning: Systematic review and recommendations from the EXTRIP workgroup	4
Incidence of viral and fungal complications after utilization of alternative donor sources in hematopoietic cell transplantation	4
Anticoagulation strategies in patients with extracorporeal membrane oxygenation: A network meta‐analysis and systematic review	4
Prophylaxis for Pneumocystis jirovecii pneumonia in patients with inflammatory bowel disease: A systematic review	4
Acute Graft‐versus‐Host Disease: Emerging Insights and Updates into Detection, Prevention, and Treatment	4
Impact of CYP3A5 phenotype on tacrolimus time in therapeutic range and clinical outcomes in pediatric renal and heart transplant recipients	4
COVID‐19: Important Therapy Considerations and Approaches in this Hour of Need	4
Scoping review of rational polytherapy in patients with drug‐resistant epilepsy	4
Choice of Acid Suppressant Therapy and Long‐Term Graft Outcomes After Kidney Transplantation	4
Vancomycin plus ceftaroline for persistent methicillin‐resistant Staphylococcus aureus bacteremia	4
Examining the clinical impact of rapid multiplex polymerase chain reaction‐based diagnostic testing for bloodstream infections in a national cohort of the Veterans Health Administration	4
Implications for body weight extremes in solid organ transplantation	4
Management of noncardiovascular comorbidities in patients with heart failure with reduced ejection fraction	4
Optimizing rapid diagnostics and diagnostic stewardship in Gram‐negative bacteremia	4
Impact of SGLT2 inhibitors on cardiovascular outcomes in patients with heart failure with reduced ejection fraction	4
Time to defervescence evaluation for extended‐ vs. standard‐infusion cefepime in patients with acute leukemia and febrile neutropenia	4
Performance of different body weights in the Cockcroft‐Gault equation in critically ill patients with and without augmented renal clearance: A multicenter cohort	4
Efficacy of inactivated vaccines in patients treated with immunosuppressive drug therapy	4
Personalized antiseizure medication therapy in critically ill adult patients	4
Non‐steroidal Anti‐inflammatory Drugs and the Risk of Pneumonia Complications: A Systematic Review	4
Colchicine for Secondary Cardiovascular Prevention: A Systematic Review	3
Use of naldemedine is associated with reduced incidence of hyperactive delirium in cancer patients with opioid‐induced constipation: A nationwide retrospective cohort study in Japan	3
Characterization of antiplatelet response to low‐dose cangrelor utilizing platelet function testing in neuroendovascular patients	3
Dexmedetomidine for prevention of opioid/benzodiazepine withdrawal syndrome in pediatric intensive care unit: Interim analysis of a randomized controlled trial	3
New ways of using old antibiotics in pediatrics: Focus on fosfomycin	3
Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression	3
Risk of parkinsonism and related movement disorders with gabapentinoids or tramadol: A case‐crossover study	3
Vancomycin Area Under the Curve‐guided Dosing and Monitoring: “Is the Juice Worth the Squeeze”?	3
Analysis of the frequency distribution of five single‐nucleotide polymorphisms of the MTRRgene in a Chinese pediatric population with acute lymphoblastic leukemia	3
Considerations and controversies of pharmacologic management of the pediatric kidney transplant recipient	3
Comparison of nimodipine formulations and administration techniques via enteral feeding tubes in patients with aneurysmal subarachnoid hemorrhage: A multicenter retrospective cohort study	3
The immunomodulatory effects of opioids and implications for intensive care unit populations	3
Reduced risk of NSAID‐Induced adverse events with concomitant use of misoprostol (MICRO study)	3
Elbasvir/grazoprevir administered for 12 weeks via percutaneous endoscopic gastrostomy tube achieves sustained virologic response: A case report and a review of the literature	3
The impact of pretransplant opioid exposure on healthcare utilization and costs in kidney transplant	3
Role of lipoprotein(a) in atherosclerotic cardiovascular disease: A review of current and emerging therapies	3
Population Pharmacokinetic Study of Vancomycin in Chinese Pediatric Patients with Hematological Malignancies	3
Dosage exploration of meloxicam according to CYP2C9 genetic polymorphisms based on a population pharmacokinetic‐pharmacodynamic model	3
Impact of timing and dosing of four‐factor prothrombin complex concentrate administration on outcomes in warfarin‐associated intracranial hemorrhage	3
Comparison of catheter‐related bloodstream infection rates in pediatric patients receiving parenteral nutrition with soybean oil‐based intravenous fat emulsion versus a mixed oil fat emulsion	3
Management of diffuse alveolar hemorrhage in the hematopoietic stem cell transplantation population: A systematic review	3
Hydroxyurea for children with sickle cell disease in sub‐Saharan Africa: A summary of the evidence, opportunities, and challenges	3
Clinical and economic evaluation of a surveillance protocol to manage hepatitis B virus (HBV) reactivation among lymphoma patients with resolved HBV infection receiving rituximab	3
Effects of aging on clinical outcomes in patients receiving genotype‐guided P2Y12 inhibitor selection after percutaneous coronary intervention	3
Contribution of pharmaceutical drugs of dependence to the incidence of neonatal abstinence syndrome in Western Australia between 2003 and 2018	3
Levetiracetam‐associated behavioral adverse events in neurocritical care patients	3
Use of hormonal contraceptives in perimenopause: A systematic review	3
The Cardiovascular Effects of Treatment with Hydroxychloroquine and Azithromycin	3
Alemtuzumab clearance, lymphocyte count, and T‐cell chimerism after hematopoietic stem cell transplant in sickle cell disease	3
Insulin NPH for steroid‐induced hyperglycemia: Predictors for success	3
Outcomes of adult patients in the intensive care unit with Pseudomonasaeruginosa pneumonia who received an active anti‐pseudomonal β‐lactam: Does “S” equal success in the presence of res	2
Characterization of Risk Factors for Genitourinary Infections with Sodium‐Glucose Cotransporter‐2 Inhibitors	2
Randomized controlled trial to compare safety and efficacy of mycophenolate vs. cyclosporine after rituximab in children with steroid‐resistant nephrotic syndrome	2
Temporal shifts in safety and efficacy profile of mycophenolate mofetil 2 g versus 3 g daily early after heart transplantation	2
The incidence of torsades de pointes with peri‐operative low‐dose ondansetron administration	2
Dosing implications for liposomal amphotericin B in pregnancy	2
	2
The incidence of cytomegalovirus and BK polyomavirus infections in kidney transplant patients receiving mTOR inhibitors: A systematic review and meta‐analysis	2
Pharmacogenomics and beyond! Customized pharmacotherapy for solid organ transplant recipients	2
Maintenance Strategies After Hematopoietic Cell Transplantation	2
Is ketamine infusion effective and safe as an adjuvant of sedation in the PICU? Results from the Ketamine Infusion Sedation Study (KISS)	2
A systematic review of opioid use and multimodal strategies in solid organ transplant recipients and living donors	2
Drug repurposing of dextromethorphan as a cellular target for the management of influenza	2
Current pharmacotherapy management of children and adults with pericarditis: Prospectus for improved outcomes	2
Renal function estimating equations performance during pregnancy and postpartum	2
Personalizing prevention: Advances in pharmacotherapy for HIV prevention	2
Accuracy of a single‐lead mobile smartphone electrocardiogram for QT interval measurement in patients undergoing maintenance methadone therapy	2
International consensus recommendations for the use of prolonged‐infusion beta‐lactam antibiotics: Endorsed by the American College of Clinical Pharmacy, British Society for Antimicrobial Chemotherapy	2
Approaches to Precision‐based Anticoagulation management in the critically Ill	2
Performance of nasal methicillin‐resistant Staphylococcus aureus screening for intra‐abdominal infections in critically ill adult patients	2
A propensity score‐matching analysis of angiotensin‐converting enzyme inhibitor and angiotensin receptor blocker exposure on in‐hospital mortality in patients with acute respiratory failure	2
High prescribing of antibiotics is associated with high prescribing of opioids in medical and dental providers	2
Oral fluoroquinolones and risk of aortic aneurysm or dissection: A nationwide population‐based propensity score‐matched cohort study	2
Path of least recurrence: A systematic review and meta‐analysis of fidaxomicin versus vancomycin for Clostridioides difficile infection	2
Effectiveness of sacubitril/valsartan versus aldosterone antagonists in heart failure with reduced ejection fraction: A retrospective cohort study	2
Analysis of fentanyl pharmacokinetics, and its sedative effects and tolerance in critically ill children	2
Steno‐sphere: Navigating the enigmatic world of emerging multidrug‐resistantStenotrophomonas maltophilia	2
Population pharmacokinetics of linezolid and its major metabolites PNU‐142300 and PNU‐142586 in adult patients	2